Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes on Insulin ± Metformin Regimens

被引：0
|
作者：
Katz, Arie
Yeh, Helen
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1224-P
引用
收藏
页码：A317 / A317
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens
    Yeh, H.
    Katz, A.
    [J]. DIABETOLOGIA, 2015, 58 : S357 - S357
  • [2] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [3] Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial
    Yang, Wenying
    Han, Ping
    Min, Kyung-Wan
    Wang, Bei
    Mansfield, Traci
    T'Joen, Caroline
    Iqbal, Nayyar
    Johnsson, Eva
    Ptaszynska, Agata
    [J]. JOURNAL OF DIABETES, 2016, 8 (06) : 796 - 808
  • [4] Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years
    Wilding, J. P. H.
    Woo, V.
    Rohwedder, K.
    Sugg, J.
    Parikh, S.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 124 - 136
  • [5] Efficacy and Safety of Saxagliptin Added to Insulin With or Without Metformin in Chinese Patients with Type 2 Diabetes
    Chen, Yingli
    Liu, Xiaomin
    Li, Quanmin
    Ma, Jianhua
    Lv, Xiaofeng
    Guo, Lixin
    Wang, Changjiang
    Shi, Yongquan
    Li, Yanbing
    Johnsson, Eva
    Wang, Mei
    Zhao, June
    Ji, Linong
    [J]. DIABETES, 2017, 66 : A329 - A329
  • [6] Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes
    Li, Xiaolong
    Sun, Dianjing
    Zhang, Yan
    Gu, Wei
    Zheng, Kunjie
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (04) : 1349 - 1354
  • [7] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes: Outcomes by Race and Ethnicity
    Moran, Jason
    Yeh, Helen
    Katz, Arie
    [J]. DIABETES, 2015, 64 : A315 - A315
  • [8] Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure
    Kosiborod, Mikhail
    Gause-Nilsson, Ingrid
    Xu, John
    Sonesson, Christian
    Johnsson, Eva
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1215 - 1221
  • [9] Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients
    Kaku, Kohei
    Inoue, Satoshi
    Matsuoka, Osamu
    Kiyosue, Arihiro
    Azuma, Haruna
    Hayashi, Nobuya
    Tokudome, Takuto
    Langkilde, Anna Maria
    Parikh, Shamik
    [J]. DIABETES, 2012, 61 : A260 - A260
  • [10] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in patients with type 2 diabetes
    Lee, J.
    Duran-Garcia, S.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    [J]. DIABETOLOGIA, 2013, 56 : S355 - S355
12345